Search results
Results From The WOW.Com Content Network
On Friday, Nasdaq Inc’s (NASDAQ:NDAQ) annual reconstitution of the Nasdaq-100 Index will become effective before the market opens on December 23. Illumina, Inc. (NASDAQ:ILMN) was removed from ...
Illumina’s (NASDAQ:ILMN) strong growth and tremendous potential make ILMN stock worth buying. Source: Shutterstock It’s true that the company’s shares are not at all cheap. Still, the demand ...
In the latest trading session, Illumina (ILMN) closed at $199.32, marking a -1.64% move from the previous day.
San Diego-based Illumina's shareholders received one share of Grail for every six shares of Illumina stock they owned as of June 13. Illumina founded the company and spun it off in 2016.
Illumina expects full-year adjusted profit per share to be between $0.75 and $0.90, compared with its prior forecast of $1.25 to $1.50. The outlook reflects a tax expense impact of about $75 million.
In September 2020, Illumina announced a proposed cash and stock deal to acquire Grail for $8 billion. [28] [29] In November 2018, Illumina proposed the acquisition of Pacific Biosciences for $8.00 per share or around $1.2 billion in total. [30] [31] In December 2019, the Federal Trade Commission (FTC) sued to block the acquisition. [32]
Illumina, Inc. (NASDAQ:ILMN) shareholders might be concerned after seeing the share price drop 12% in the last...
Investors are optimistic about Illumina's (ILMN) strategic collaborations and strong international sales.